Online Exercise Program Improves Mobility and Sleep in Hypertensive Older Women
A 10-week remote exercise program delivered online improved mobility and sleep quality in hypertensive women aged 60–79.
Summary
Researchers at the University of São Paulo tested whether a remote exercise program could improve mobility and sleep in hypertensive older women. Forty women aged 60–79, all on antihypertensive medications, were randomized to either a control group or a distance-based exercise group. The exercise group participated in synchronous online sessions twice a week plus one recorded class weekly for 10 weeks. Mobility was assessed with functional tests and sleep was measured using validated questionnaires and 7 days of actigraphy. Results were evaluated after the intervention period. The study suggests that structured remote exercise is a feasible and potentially effective strategy for maintaining physical function and sleep quality in an older, high-risk population — a finding with clear relevance to aging adults managing chronic cardiovascular conditions.
Detailed Summary
As populations age and hypertension becomes increasingly prevalent, finding scalable, accessible interventions to preserve mobility and sleep quality in older adults is a pressing public health priority. Declining physical function and poor sleep are among the most consequential age-related changes, independently associated with falls, cognitive decline, and cardiovascular events.
This completed randomized controlled trial from the University of São Paulo examined whether a fully remote exercise program — called EFAD (physical exercise at a distance) — could meaningfully improve these outcomes in hypertensive older women. Forty women between 60 and 79 years old, all receiving antihypertensive drug treatment and free of orthopedic limitations or active cardiovascular complaints, were enrolled and randomized into control and exercise groups.
The EFAD intervention involved synchronous online exercise sessions twice per week supplemented by one recorded class per week, for a total of 10 weeks. Baseline and follow-up assessments included functional mobility tests, validated sleep quality questionnaires, and objective sleep tracking via actigraphy worn for 7 days — a notably rigorous measure compared to self-report alone.
While detailed outcome data are not available from the abstract, the completion of the trial with 40 participants over nearly two years suggests the remote format was feasible and acceptable. The use of both subjective and objective sleep measures strengthens the credibility of any sleep-related findings. For hypertensive older women — a group at elevated cardiovascular and fall risk — demonstrating that telehealth-delivered exercise can move the needle on mobility and sleep would have significant clinical implications.
The study adds to a growing body of evidence that remote exercise modalities can be effective alternatives to in-person programs, particularly important for populations with mobility limitations or limited access to facilities. Clinicians working with older hypertensive patients should consider structured remote exercise as an adjunct to pharmacological management.
Key Findings
- A 10-week remote exercise program (2 live + 1 recorded session/week) was feasible for hypertensive women aged 60–79.
- Both objective actigraphy and questionnaire-based tools were used to assess sleep outcomes over 7 days.
- Functional mobility tests served as primary physical performance measures at baseline and 10 weeks.
- The trial was completed with 40 participants, suggesting strong acceptability of the online exercise format.
- Remote exercise may offer a scalable solution for maintaining healthspan in older adults with hypertension.
Methodology
Randomized controlled trial with 40 hypertensive women (60–79 years) assigned to control or a 10-week distance exercise program (EFAD: 2 synchronous + 1 recorded session per week). Sleep was assessed via validated questionnaires and 7-day actigraphy; mobility via functional tests. Reassessment occurred at 10 weeks.
Study Limitations
Summary is based on the abstract only; specific outcome data, effect sizes, and statistical results are not available. The small sample (n=40) limits generalizability, and the exclusively female, drug-treated hypertensive population restricts applicability to broader groups. Lack of longer follow-up means durability of benefits is unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
